In contrast, several other studies reported the anticancer properties of equol mainly mediated via reduced expression of MMP, which results in impaired metastasis characteristics in breast cancer cells, as well as enhanced demethylation of BRCA1 and BRCA2 promoters that reduces the risk of early onset of breast cancer [57]. The gene discussed is BRCA1; the disease is breast carcinoma.